# Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children

> **NCT00796315** · PHASE1 · COMPLETED · sponsor: **Procter and Gamble** · enrollment: 41 (actual)

## Conditions studied

- Allergic Rhinitis
- Upper Respiratory Infection

## Interventions

- **DRUG:** Doxylamine Succinate USP

## Key facts

- **NCT ID:** NCT00796315
- **Lead sponsor:** Procter and Gamble
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2013-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00796315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00796315, "Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00796315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*